Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Anestezjol Intens Ter ; 41(1): 41-5, 2009.
Artigo em Polonês | MEDLINE | ID: mdl-19517677

RESUMO

BACKGROUND: New diseases and therapies that lead to marked immunocompromise, have brought to medicine so-called opportunistic infections, caused by pathogens that usually do not cause disease in the presence of a healthy immune system. First diagnosed in AIDS patients, opportunistic infections have appeared in many other situations, including transplant recipients, other immunosuppressed patients, and even in otherwise healthy patients undergoing major elective surgery. Among the most common pathogens causing atypical infections are: Pneumocistis jiroveci, Chlamydia, Mycoplasma and Legionella. The aim of this retrospective study was to assess the incidence of the above mentioned infections in cardiac surgical patients whose early postoperative period was complicated by respiratory distress. METHODS: The postoperative course of 5026 cardiac surgical patients was analysed retrospectively. In 196 cases (3.9%), important respiratory complications, defined as prolonged (>24h) requirement for mechanical ventilation, pulmonary oedema, atelectasis, pneumothorax, haemothorax, infiltrations present on chest x-ray, or ARDS, were detected. RESULTS: Positive atypical sputum cultures (Chlamydia pneumoniae, Mycoplasma pneumoniae or Pneumocistis jiroveci) were obtained from 27 patients (16%). Pneumocistis jiroveci was the most common pathogen identified. Legionella pneumoniae was never cultured. The average duration of mechanical ventilation in the study group was 253 h, and the mortality 18.5% (5 patients). CONCLUSIONS: Opportunistic infection with atypical pathogens should be suspected in the postoperative period when complicated by prolonged respiratory distress and difficulties with weaning from mechanical ventilation. Since these infections do not present with obvious symptoms, the diagnostic process should be extended and appropriate treatment introduced.


Assuntos
Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Infecções Oportunistas/microbiologia , Respiração Artificial/efeitos adversos , Infecções Respiratórias/microbiologia , Idoso , Infecções por Chlamydia/microbiologia , Chlamydophila pneumoniae/isolamento & purificação , Feminino , Humanos , Incidência , Doença dos Legionários/microbiologia , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/epidemiologia , Pneumocystis carinii/isolamento & purificação , Pneumonia por Mycoplasma/microbiologia , Pneumonia por Pneumocystis/microbiologia , Polônia/epidemiologia , Infecções Respiratórias/epidemiologia , Estudos Retrospectivos , Escarro/microbiologia
2.
Ann Transplant ; 8(1): 37-9, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12848381

RESUMO

A retrospective analysis was performed on the records of 95 pts who underwent heart transplantation at Dept. Of Cardiac Surgery & Transplantation in 1999 and 2000 y. In 34 pts lower respiratory tract infections were observed. In all cases bacterial factor was detected in sputum or bronchoalveolar lavage. In study population we analysed influence of such factors as age of the patients, the intensity and duration of immunosuppression, pre-existing diseases and timing after transplantation on the incidence of infection. Most often, in 43 pts gram negative stains bacteria was detected. Pseudomonas aeruginosa (15 pts), Acinetobacter baumanii (7 pts) and Enterobacter cloacae (6 pts) were predominant. Gram positive stains bacteria was detected only in two cases (Streptococcus pneumoniae and Staphylococcus aureus). In 1 pt we observed lung tuberculosis and in 2 pts Pneumocystis carinii pneumonia. Older recipient age was the only risk factor leading to occurrence of respiratory tract infections in patients after heart transplantation.


Assuntos
Infecções Bacterianas/epidemiologia , Infecções Bacterianas/etiologia , Transplante de Coração/efeitos adversos , Hospitalização , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/etiologia , Doença Aguda , Adulto , Envelhecimento , Infecções Bacterianas/microbiologia , Feminino , Rejeição de Enxerto/complicações , Humanos , Imunossupressores/efeitos adversos , Incidência , Masculino , Pessoa de Meia-Idade , Infecções Respiratórias/microbiologia , Estudos Retrospectivos , Fatores de Risco
3.
Ann Transplant ; 8(1): 42-4, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12848382

RESUMO

Pulmonary infections remain the leading cause of death in patients after heart transplantation. Lung tuberculosis is more common in transplant recipients than in general population. Two cases of tuberculosis are presented in patients after heart transplantation. Regarding to influence of rifampicin on immunosuppressive therapy, those patients were treated with antimycobacterial drugs except rifampicin. A cure without recurrence can be achieved with a scheme of treatment regimes without rifampicin.


Assuntos
Antituberculosos/uso terapêutico , Transplante de Coração/efeitos adversos , Terapia de Imunossupressão/efeitos adversos , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/etiologia , Adulto , Antituberculosos/efeitos adversos , Ciclosporina/administração & dosagem , Ciclosporina/efeitos adversos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Quimioterapia Combinada , Humanos , Terapia de Imunossupressão/métodos , Imunossupressores/administração & dosagem , Imunossupressores/efeitos adversos , Masculino , Rifampina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA